Narrow Results Clear All
Search results for "North America"
Journal Article > Commentary
Franklin GM. Neurology. 2014;83:1277-1284.
Risk associated with the opioid use has been identified as a growing patient safety concern in the United States. This position paper describes why this problem is emerging, reviews evidence and policy to guide safe opioid prescribing for pain management, and includes recommendations for neurologists to reduce the likelihood of adverse events involving these high-risk medications, such as improved prescription monitoring.
Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication use error—reports of accidental overdose.
MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; January 10, 2011.
This announcement reveals a labeling change to reduce the potential for misadministration of a pain medication.